頭痛疾患の世界市場レポート 2025年

頭痛疾患市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.8％で69億9,000万米ドルに成長します。予測期間の成長は、デジタルヘルスソリューション、個別化医療アプローチ、研究開発投資の増加、世界の高齢化、神経炎症研究の拡大に起因すると考えられます。予測期間における主な動向には、治療における技術的進歩、個別化医療、予防治療への注目の高まり、新規治療のパイプラインの拡大、非薬理学的アプローチの増加などがあります。

片頭痛の有病率の上昇は、今後の頭痛疾患市場の成長を牽引すると予測されます。片頭痛は、中等度から重度のズキズキする痛みの再発を特徴とする特定のタイプの頭痛であり、一般的に頭の片側が痛みます。頭痛疾患は、片頭痛の引き金となる衰弱性の痛み、疲労、吐き気を引き起こす神経学的状態につながる可能性があります。例えば、2022年4月、英国の専門誌「Journal of Headache and Pain」に掲載された研究によると、調査対象者の52.0％が何らかの活動性頭痛障害を経験しており、その有病率は男性で44.4％、女性で57.8％でした。片頭痛は人口の14.0％（男性8.6％、女性17.0％）にみられ、緊張型頭痛（TTH）は人口の26.0％にみられ、男性の23.4％、女性の27.1％にみられました。その結果、片頭痛の有病率の増加が頭痛疾患市場の需要を促進しています。

個別化医療への注目の高まりは、今後数年間における頭痛疾患市場の成長を促進すると予想されます。個別化医療は、精密医療とも呼ばれ、個人の特徴に応じて医療上の決定、実践、介入をカスタマイズする医療とヘルスケアへの革新的なアプローチを表しています。この頭痛疾患に合わせた治療アプローチは、各患者の治療成果を最適化するために、遺伝的、分子的、ライフスタイル的要因に基づく個別化戦略を含みます。例えば、2023年2月、個別化医療の導入を提唱する米国を拠点とする組織である個別化医療連合（The Personalized Medicine Coalition）は、2022年にFDAが12の個別化医薬品を承認し、新たに承認された全治療分子実体の約34％を占めたと報告しました。したがって、個別化医療への注目の高まりが、頭痛障害市場を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界頭痛疾患PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
• 最終用途産業の分析
• 世界の頭痛疾患市場：成長率分析
• 世界の頭痛疾患市場の実績：規模と成長, 2019-2024
• 世界の頭痛疾患市場の予測：規模と成長, 2024-2029, 2034F
• 世界頭痛疾患総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の頭痛疾患市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 片頭痛
• 緊張型頭痛
• 群発性頭痛
• 薬物乱用による頭痛
• その他のタイプ
• 世界の頭痛疾患市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬
• 温熱療法
• 食生活の変化
• 鍼
• 酸素療法
• 世界の頭痛疾患市場診断による、実績と予測, 2019-2024, 2024-2029F, 2034F
• 完全血球計算
• 頭蓋骨のX線写真
• 副鼻腔X線検査
• CTスキャン
• 磁気共鳴画像（MRI）
• 世界の頭痛疾患市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 非経口
• その他の投与経路
• 世界の頭痛疾患市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• ホームケア
• その他のエンドユーザー
• 世界の頭痛疾患市場片頭痛の種類によるサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 慢性片頭痛
• 反復性片頭痛
• オーラを伴う片頭痛
• 前兆のない片頭痛
• 世界の頭痛疾患市場緊張型頭痛の分類、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 断続性緊張型頭痛
• 慢性緊張型頭痛
• 世界の頭痛疾患市場群発性頭痛のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 慢性群発性頭痛
• 反復性群発頭痛
• 世界の頭痛疾患市場薬物乱用頭痛のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 鎮痛剤の過剰使用による頭痛
• カフェイン離脱頭痛
• 世界の頭痛疾患市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 副鼻腔頭痛
• ホルモン性頭痛
• 雷鳴頭痛
• その他の一次性および二次性頭痛

第7章 地域別・国別分析

• 世界の頭痛疾患市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の頭痛疾患市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 頭痛疾患市場：競合情勢
• 頭痛疾患市場：企業プロファイル
  • Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Hikma Pharmaceuticals PLC Overview, Products and Services, Strategy and Financial Analysis
  • Dr. Reddy's Laboratories Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• F. Hoffmann-La Roche Ltd.
• Sun Pharmaceutical Industries Ltd
• Emcure Pharmaceuticals Limited
• Endo International plc
• WorldMeds LLC
• AstraZeneca plc
• Bausch & Lomb Incorporated
• Nichi-Iko Pharmaceutical Co
• Upsher-Smith Laboratories LLC
• Bristol-Myers Squibb Company
• Bayer AG
• Boehringer Ingelheim International GmbH.
• Gilead Sciences Inc.
• Amgen Inc.
• Pfizer Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 頭痛疾患市場2029：新たな機会を提供する国
• 頭痛疾患市場2029：新たな機会を提供するセグメント
• 頭痛疾患市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Headache disorder is a neurological condition characterized by recurrent and severe headaches that typically manifest on one side of the head, often around the eye region. This disorder imposes a significant burden on individuals, leading to substantial personal pain, reduced quality of life, and financial implications.

The primary types of headache disorders include migraine, tension-type headaches, cluster headaches, medication-overuse headaches, and others. Migraine headaches are distinguished by intense throbbing pain or pulsating sensations, usually localized on one side of the head. Various treatments for headache disorders include medications, heat therapy, dietary modifications, acupuncture, and oxygen therapy. Diagnosis involves procedures such as complete blood count, skull x-rays, sinus x-rays, CT scans, and magnetic resonance imaging (MRI). Treatment methods encompass oral administration, parenteral routes, and other modalities, with applications in hospitals, specialty clinics, homecare, and other healthcare settings.

The headache disorders market research report is one of a series of new reports from The Business Research Company that provides headache disorders market statistics, including headache disorders industry global market size, regional shares, competitors with headache disorders market share, detailed headache disorders market segments, market trends, and opportunities, and any further data you may need to thrive in the headache disorders industry. This headache disorders market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The headache disorders market size has grown strongly in recent years. It will grow from $4.64 billion in 2024 to $4.98 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to limited treatment options, growing awareness, rising incidence of headaches, evolving healthcare infrastructure, shift in lifestyle and stress levels.

The headache disorders market size is expected to see strong growth in the next few years. It will grow to $6.99 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to digital health solutions, personalized medicine approaches, increasing research and development investments, global aging population, expansion of research in neuroinflammation. Major trends in the forecast period include technological advancements in treatment, personalized medicine, increased focus on preventive therapies, expanding pipeline of novel therapies, and rise in non-pharmacological approaches.

The rising prevalence of migraines is projected to drive the growth of the headache disorders market in the future. A migraine is a specific type of headache characterized by recurrent episodes of moderate to severe throbbing pain, typically on one side of the head. Headache disorders can lead to neurological conditions that cause debilitating pain, fatigue, and nausea, which may trigger migraines. For example, in April 2022, a study published in the Journal of Headache and Pain, a UK-based peer-reviewed journal, found that 52.0% of the studied population experienced some form of active headache disorder, with a prevalence of 44.4% among males and 57.8% among females. Migraines affected 14.0% of the population (8.6% in males and 17.0% in females), while tension-type headaches (TTH) were present in 26.0% of the population, affecting 23.4% of males and 27.1% of females. Consequently, the growing prevalence of migraines is fueling demand in the headache disorders market.

The rising emphasis on personalized medicine is expected to drive the growth of the headache disorder market in the coming years. Personalized medicine, also referred to as precision medicine, represents an innovative approach to medical treatment and healthcare that customizes medical decisions, practices, and interventions according to individual characteristics. This tailored treatment approach for headache disorders involves personalized strategies based on genetic, molecular, and lifestyle factors to optimize therapeutic outcomes for each patient. For instance, in February 2023, The Personalized Medicine Coalition, a U.S.-based organization advocating for the adoption of personalized medicine, reported that in 2022, the FDA approved 12 personalized medicines, making up approximately 34% of all newly approved therapeutic molecular entities. Therefore, the increased focus on personalized medicine is propelling the headache disorder market.

Leading companies in the headache disorder market are concentrating on creating innovative products, such as migraine tablets, to enhance treatment options and improve patient outcomes. Migraine tablets are designed to relieve or prevent migraine attacks by targeting specific pathways involved in migraine symptoms like pain and inflammation. For example, in January 2024, Akums Drugs & Pharmaceuticals, an India-based pharmaceutical manufacturer, introduced the Lasmiditan Tablet, a generic version of Eli Lilly's REYVOW, intended for the acute treatment of migraines. Approved by both the Drug Controller General of India (DCGI) and the U.S. Food and Drug Administration (USFDA), Lasmiditan works by binding to the 5-HT1F serotonin receptor, blocking pain signals, and reducing nerve inflammation. The recommended dosage ranges from 50 mg to 100 mg, with a maximum of one dose permitted within a 24-hour period.

Major players in the headache disorder market are also focused on developing innovative products like migraine nasal sprays to deliver faster relief by administering medication directly through the nasal passages, thereby enhancing treatment efficacy for patients. Migraine nasal sprays are rapid-acting treatments that offer quicker relief from migraine symptoms, especially beneficial for those who suffer from nausea or have difficulty swallowing pills. For instance, in March 2023, Pfizer Inc., a U.S.-based pharmaceutical and biotechnology company, gained FDA approval for ZAVZPRET, the first nasal spray calcitonin gene-related peptide (CGRP) receptor antagonist for the acute treatment of migraines in adults. Demonstrating significant efficacy in clinical trials, ZAVZPRET can provide pain relief in as little as 15 minutes and is suitable for use with or without aura, with a recommended dosage of one 10 mg spray in a single nostril per day. While it is generally well-tolerated, common side effects may include taste disorders and nausea.

In May 2022, Man and Science SA, a Belgium-based medical device firm, acquired Palion Medical AS for an undisclosed amount. This acquisition aligns well with Man and Science's headache treatment offerings and enhances its capacity to provide various therapeutic solutions aimed at improving patient care. Palion Medical AS is a Germany-based clinical-stage medical device company focused on developing precision injection solutions for individuals suffering from debilitating chronic migraines and cluster headaches.

Major companies operating in the headache disorders market include Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories Ltd, Novartis AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Sun Pharmaceutical Industries Ltd, Emcure Pharmaceuticals Limited, Endo International plc, WorldMeds LLC, AstraZeneca plc, Bausch & Lomb Incorporated, Nichi-Iko Pharmaceutical Co, Upsher-Smith Laboratories LLC, Bristol-Myers Squibb Company, Bayer AG, Boehringer Ingelheim International GmbH., Gilead Sciences Inc., Amgen Inc., Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Eisai Co. Ltd., Impax Laboratories LLC, Lannett Company Inc., Lupin Pharmaceuticals Inc.

North America was the largest region in the headache disorders market in 2024. The regions covered in the headache disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the headache disorders market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The headache disorders market includes revenues earned by entities by providing analgesics, anti-emetics, specific anti-migraine medications, and prophylactic medications. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Headache Disorders Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on headache disorders market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for headache disorders ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The headache disorders market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Migraine; Tension-Type Headache; Cluster Headache; Medication-Overuse Headache; Other Types
• 2) By Treatment: Medication; Heat Therapy; Diet Changes; Acupuncture; Oxygen Therapy
• 3) By Diagnosis: Complete Blood Count; Skull X-Rays; Sinus X-Rays; CT Scan; Magnetic Resonance Imaging (MRI)
• 4) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations
• 5) By End-User: Hospitals; Specialty Clinics; Homecare; Other End-Users
• Subsegments:
• 1) By Migraine: Chronic Migraine; Episodic Migraine; Migraine With Aura; Migraine Without Aura
• 2) By Tension-Type Headache: Episodic Tension-Type Headache; Chronic Tension-Type Headache
• 3) By Cluster Headache: Chronic Cluster Headache; Episodic Cluster Headache
• 4) By Medication-Overuse Headache: Analgesic-Overuse Headache; Caffeine-Withdrawal Headache
• 5) By Other Types: Sinus Headache; Hormonal Headache; Thunderclap Headache; Other Primary And Secondary Headaches
• Companies Mentioned: Teva Pharmaceutical Industries Ltd.; Hikma Pharmaceuticals PLC; Dr. Reddy's Laboratories Ltd; Novartis AG; Eli Lilly and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Headache Disorders Market Characteristics

3. Headache Disorders Market Trends And Strategies

4. Headache Disorders Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Headache Disorders Growth Analysis And Strategic Analysis Framework

• 5.1. Global Headache Disorders PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Headache Disorders Market Growth Rate Analysis
• 5.4. Global Headache Disorders Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Headache Disorders Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Headache Disorders Total Addressable Market (TAM)

6. Headache Disorders Market Segmentation

• 6.1. Global Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Migraine
• Tension-Type Headache
• Cluster Headache
• Medication-Overuse Headache
• Other Types
• 6.2. Global Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Heat Therapy
• Diet Changes
• Acupuncture
• Oxygen Therapy
• 6.3. Global Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Complete Blood Count
• Skull X-Rays
• Sinus X-Rays
• CT Scan
• Magnetic Resonance Imaging (MRI)
• 6.4. Global Headache Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Route Of Administrations
• 6.5. Global Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Homecare
• Other End-Users
• 6.6. Global Headache Disorders Market, Sub-Segmentation Of Migraine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Migraine
• Episodic Migraine
• Migraine With Aura
• Migraine Without Aura
• 6.7. Global Headache Disorders Market, Sub-Segmentation Of Tension-Type Headache, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Episodic Tension-Type Headache
• Chronic Tension-Type Headache
• 6.8. Global Headache Disorders Market, Sub-Segmentation Of Cluster Headache, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Cluster Headache
• Episodic Cluster Headache
• 6.9. Global Headache Disorders Market, Sub-Segmentation Of Medication-Overuse Headache, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Analgesic-Overuse Headache
• Caffeine-Withdrawal Headache
• 6.10. Global Headache Disorders Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sinus Headache
• Hormonal Headache
• Thunderclap Headache
• Other Primary And Secondary Headaches

7. Headache Disorders Market Regional And Country Analysis

• 7.1. Global Headache Disorders Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Headache Disorders Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Headache Disorders Market

• 8.1. Asia-Pacific Headache Disorders Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Headache Disorders Market

• 9.1. China Headache Disorders Market Overview
• 9.2. China Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Headache Disorders Market

• 10.1. India Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Headache Disorders Market

• 11.1. Japan Headache Disorders Market Overview
• 11.2. Japan Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Headache Disorders Market

• 12.1. Australia Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Headache Disorders Market

• 13.1. Indonesia Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Headache Disorders Market

• 14.1. South Korea Headache Disorders Market Overview
• 14.2. South Korea Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Headache Disorders Market

• 15.1. Western Europe Headache Disorders Market Overview
• 15.2. Western Europe Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Headache Disorders Market

• 16.1. UK Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Headache Disorders Market

• 17.1. Germany Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Headache Disorders Market

• 18.1. France Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Headache Disorders Market

• 19.1. Italy Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Headache Disorders Market

• 20.1. Spain Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Headache Disorders Market

• 21.1. Eastern Europe Headache Disorders Market Overview
• 21.2. Eastern Europe Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Headache Disorders Market

• 22.1. Russia Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Headache Disorders Market

• 23.1. North America Headache Disorders Market Overview
• 23.2. North America Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Headache Disorders Market

• 24.1. USA Headache Disorders Market Overview
• 24.2. USA Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Headache Disorders Market

• 25.1. Canada Headache Disorders Market Overview
• 25.2. Canada Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Headache Disorders Market

• 26.1. South America Headache Disorders Market Overview
• 26.2. South America Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Headache Disorders Market

• 27.1. Brazil Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Headache Disorders Market

• 28.1. Middle East Headache Disorders Market Overview
• 28.2. Middle East Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Headache Disorders Market

• 29.1. Africa Headache Disorders Market Overview
• 29.2. Africa Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Headache Disorders Market Competitive Landscape And Company Profiles

• 30.1. Headache Disorders Market Competitive Landscape
• 30.2. Headache Disorders Market Company Profiles
  • 30.2.1. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Hikma Pharmaceuticals PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Dr. Reddy's Laboratories Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Headache Disorders Market Other Major And Innovative Companies

• 31.1. F. Hoffmann-La Roche Ltd.
• 31.2. Sun Pharmaceutical Industries Ltd
• 31.3. Emcure Pharmaceuticals Limited
• 31.4. Endo International plc
• 31.5. WorldMeds LLC
• 31.6. AstraZeneca plc
• 31.7. Bausch & Lomb Incorporated
• 31.8. Nichi-Iko Pharmaceutical Co
• 31.9. Upsher-Smith Laboratories LLC
• 31.10. Bristol-Myers Squibb Company
• 31.11. Bayer AG
• 31.12. Boehringer Ingelheim International GmbH.
• 31.13. Gilead Sciences Inc.
• 31.14. Amgen Inc.
• 31.15. Pfizer Inc.

32. Global Headache Disorders Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Headache Disorders Market

34. Recent Developments In The Headache Disorders Market

35. Headache Disorders Market High Potential Countries, Segments and Strategies

• 35.1 Headache Disorders Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Headache Disorders Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Headache Disorders Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer